(Q48903261)

16 February 2018

title

Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors. (English)

1 reference

16 February 2018

1 reference

1 reference

1

1 reference

16 February 2018

Kjell Fuxe

2

1 reference

16 February 2018

Luigi Francesco Agnati

4

object named as

L F Agnati

1 reference

16 February 2018

author name string

G von Euler

3

1 reference

16 February 2018

L Ferraro

5

1 reference

16 February 2018

U Ungerstedt

6

1 reference

16 February 2018

publication date

1 September 1990

1 reference

16 February 2018

Naunyn-Schmiedeberg's Archives of Pharmacology

published in

1 reference

16 February 2018

volume

342

1 reference

16 February 2018

issue

3

1 reference

16 February 2018

page(s)

300-304

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00169441

exact match

0 references

cites work

Cholecystokinin neuron systems and their interactions with the presynaptic features of the dopamine neuron systems. A morphometric and neurochemical analysis involving studies on the action of cholecystokinin-8 and cholecystokinin-58.

1 reference

12 December 2020

Modulation of neurotransmitter release by presynaptic autoreceptors

1 reference

12 December 2020

Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system

1 reference

12 December 2020

Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis

1 reference

12 December 2020

Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis

1 reference

12 December 2020

Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity.

1 reference

12 December 2020

Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists

1 reference

12 December 2020

Further studies on the specificity of proglumide as a selective cholecystokinin antagonist in the central nervous system

1 reference

12 December 2020

Changes in pituitary-adrenal activity affect the binding properties of striatal dopamine D-2 receptors but not their modulation by neurotensin and cholecystokinin-8.

1 reference

12 December 2020

Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat

1 reference

12 December 2020

Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum.

1 reference

12 December 2020

Modulation by cholecystokinins of3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites

1 reference

12 December 2020

Subcortical limbic 3H-N-propylnorapomorphine binding sites are markedly modulated by cholecystokinin-8 in vitro

1 reference

12 December 2020

Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide

1 reference

12 December 2020

Dopamine Auto- and Postsynaptic Receptors: Electrophysiological Evidence for Differential Sensitivity to Dopamine Agonists

1 reference

12 December 2020

Effect of cholecystokinin-octapeptide on dopamine release from slices of cat caudate nucleus

1 reference

12 December 2020

Cholecystokinin peptides in vitro modulate the characteristics of the striatal3H-N-propylnorapomorphine sites

1 reference

12 December 2020

Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors

1 reference

12 December 2020

Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection

1 reference

12 December 2020

Evidence for dopamine receptors mediating sedation in the mouse brain

1 reference

12 December 2020

Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide

1 reference

12 December 2020

Cholecystokinin-like peptides potentiate apomorphine-induced inhibition of dopamine neurons

1 reference

12 December 2020

In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin

1 reference

12 December 2020

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

1 reference

12 December 2020

Stimulation-induced release of coexistent transmitters in the prefrontal cortex: an in vivo microdialysis study of dopamine and neurotensin release

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00169441

1 reference

16 February 2018

PubMed ID

2280797

1 reference

16 February 2018